CTFP Volume 11 Issue 9

A publication of the American Thyroid Association

Table of Contents


Welcome to another issue of Clinical Thyroidology for the Public. In this journal, we will bring to you the most up-to-date, cutting edge thyroid research. We also provide even faster updates of late-breaking thyroid news through Twitter at @ thyroidfriends and on Facebook. Our goal is to provide patients with the tools to be the most informed thyroid patient in the waiting room. Also check out our friends in the Alliance for Thyroid Patient Education. The Alliance member groups consist of: the American Thyroid Association, Bite Me Cancer, the Graves’ Disease and Thyroid Foundation, the Light of Life Foundation, ThyCa: Thyroid Cancer Survivors’ Association, Thyroid Cancer Canada, Thyroid Cancer Alliance and Thyroid Federation International.

We invite all of you to join our Friends of the ATA community. It is for you that the American Thyroid Association (ATA) is dedicated to carrying out our mission of providing reliable thyroid information and resources, clinical practice guidelines for thyroid detection and treatments, resources for connecting you with other patients affected by thyroid conditions, and cutting edge thyroid research as we search for better diagnoses and treatment outcomes for thyroid disease and thyroid cancer. We thank all of the Friends of the ATA who support our mission and work throughout the year to support us. We invite you to help keep the ATA mission strong by choosing to make a donation that suits you – it takes just one moment to give online at: www. thyroid.org/donate and all donations are put to good work. The ATA is a 501(c)3 nonprofit organization and your gift is tax deductible

October is Thyroid Nodule Awareness Month

If you are in Washington, DC, please join us for a free Patient Forum on Saturday, October 6 at the Marriot Marquis from 2–4 PM.

In this issue, the studies ask the following questions:

  • Is there an association between thyroid dysfunction in the mother and the development of autism and ADHD in the children?
  • Does the type of nodule biopsy technique affect the frequency of non-diagnostic samples?
  • Are small bright spots noted on ultrasound associated with thyroid cancer?
  • Can the ATA ultrasound classification system help determine the risk of cancer in indeterminate thyroid nodules?
  • Can a new version of a molecular marker assay improve the diagnosis of cancer in indeterminate thyroid nodules?
  • Is survival the best endpoint in determining the extent of surgery in medullary thyroid cancer?

We welcome your feedback and suggestions. Let us know what you want to see in this publication. I hope you find these summaries interesting and informative.

Alan P. Farwell, MD, FACE